1452-P: Type 1 Diabetes Subphenotypes—A Cluster Analysis
KATSIARYNA PRYSTUPA(Hochschule Düsseldorf University of Applied Sciences), Róbert Wágner(Düsseldorf University Hospital), Julia Szendroedi(Heidelberg University), Michael Roden(Düsseldorf University Hospital), Sebastian M. Meyhöfer, Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.), Klaus Straßburger(Deutsches Diabetes-Zentrum e.V.), Michael Stümvoll(University Hospital Leipzig), Andreas Fritsche(Deutsches Diabetes-Zentrum e.V.), Oana‐Patricia Zaharia(Düsseldorf University Hospital), Volker Burkart(Deutsches Diabetes-Zentrum e.V.), ANDREAS F. PFEIFFER, ALEXANDER STROM, GIDON J. BÖNHOF, Martin Heni(University Hospital Ulm), Nina Saatmann(Deutsches Diabetes-Zentrum e.V.), Jochen Seißler
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789